|
University of South Alabama Medical Center Mobile, AL 36617 Medicare Provider Number: 010087 |
Free Profile |
Identification and Characteristics
- Last updated 02/28/2012 / Definitions
|
|
Clinical Services
|
|
Joint Commission Accreditation
- Accreditation status licensed from The Joint Commission
- Last updated 02/04/2012 / Definitions and Terms of Use
- Current Status: 09/11/2010 - Accreditation with Full Standards Compliance
Approved Cancer Program
- Approval status provided by The American College of Surgeons (ACS) Commission on Cancer (CoC) Approvals Program.
- See ACS/CoC website for more / Last updated 05/10/2011 / Definitions
- Type: Teaching Hospital Cancer Program
Teaching Status
- Data are from multiple sources / Definitions
- ACGME data are from the Graduate Medical Education Database, Copyright 2005, American Medical Association, Chicago, Illinois.
- See FREIDA OnLine for more / Last Update 05/12/2011
- COTH data are from the Association of American Medical Colleges / Division of Health Care Affairs / Council of Teaching Hospitals
- See COTH website for more / Last Updated 05/13/2011
- Teaching status = Yes / Number of interns and Residents = 118 FTEs
- Actively involved as sponsor in ACGME-accredited specialty and subspecialty programs
- Major teaching hospital; member of the Council of Teaching Hospitals and Health Systems (COTH)
Inpatient Utilization Statistics by Medical Service
| Number Medicare Inpatients |
Average Length of Stay |
Average Charges |
Medicare Case Mix Index (CMI) |
|
|---|---|---|---|---|
| Burns | 50 | 9.10 | $31,420 | 3.3670 |
| Cardiology | 136 | 3.43 | $10,557 | 1.1537 |
| Cardiovascular Surgery | 51 | 6.82 | $48,216 | 3.8653 |
| Medicine | 297 | 5.07 | $13,531 | 1.2226 |
| Neurology | 112 | 5.39 | $15,717 | 1.3826 |
| Neurosurgery | 23 | 6.39 | $27,049 | 3.3791 |
| Oncology | 11 | 8.00 | $21,945 | 1.2394 |
| Orthopedic Surgery | 121 | 6.63 | $30,604 | 2.0374 |
| Orthopedics | 27 | 4.70 | $8,368 | 1.0033 |
| Pulmonology | 118 | 5.58 | $18,549 | 1.8621 |
| Surgery | 178 | 13.48 | $57,453 | 5.1869 |
| Urology | 48 | 6.10 | $17,482 | 1.5520 |
| Vascular Surgery | 61 | 6.41 | $26,246 | 2.3851 |
| Total | 1,254 | 6.69 | $24,861 | 2.2256 |
Inpatient Origin for Top 3 Zip Codes
- Medicare Hospital Market Service Area File for calendar year ending 12/31/2010 / Definitions
| ZIP Code of Residence | Discharges | Days of Care | Charges | Discharges Inc/(Dec) | Market Share |
|---|---|---|---|---|---|
| 36610 | 136 | 763 | $2,750,251 | 49.5% | 13.4% |
| 36617 | 134 | 887 | $3,047,069 | 27.6% | 10.2% |
| 36605 | 95 | 774 | $2,365,896 | -1.0% | 5.5% |
Outpatient Utilization Statistics by APC
| APC Number |
APC Description | Number Patient Claims |
Average Charge |
Average Cost |
|---|---|---|---|---|
| 9119 | Injection, pegfilgrastim 6mg | 302 | $5,233 | $1,638 |
| 9214 | Bevacizumab injection | 143 | $108 | $34 |
| 9215 | Cetuximab injection | 75 | $87 | $27 |
| 0823 | Docetaxel injection | 162 | $32 | $10 |
| 0849 | Rituximab injection | 71 | $930 | $291 |
| 0440 | Level V Drug Administration | 1,196 | $295 | $124 |
| 9213 | Pemetrexed injection | 50 | $78 | $25 |
| 9207 | Bortezomib injection | 55 | $63 | $20 |
| 1613 | Trastuzumab injection | 60 | $109 | $34 |
| 1738 | Oxaliplatin | 72 | $17 | $5 |
| 1709 | Azacitidine injection | 55 | $16 | $5 |
| 0828 | Gemcitabine hcl injection | 100 | $296 | $93 |
| 0088 | Thrombectomy | 91 | $1,546 | $1,293 |
| 0080 | Diagnostic Cardiac Catheterization | 89 | $3,443 | $1,451 |
| 0437 | Level II Drug Administration | 2,899 | $90 | $38 |
| 9210 | Palonosetron hcl | 586 | $28 | $9 |
| 9115 | Zoledronic acid | 170 | $401 | $126 |
| 1712 | Paclitaxel protein bound | 30 | $16 | $5 |
| 9245 | Romiplostim injection | 25 | $75 | $24 |
| 7046 | Doxorubicin hcl liposome inj | 28 | $754 | $236 |
Beds and Patient Days by Unit
| Available Beds | Inpatient Days | |
|---|---|---|
| HOSPITAL (including swing beds) |
||
| Routine Services | 97 | 29,989 |
| Special Care | 34 | 10,255 |
| Nursery | 0 | 0 |
| Total Hospital | 131 | 40,244 |
Financial Statistics
| $ | % | |
|---|---|---|
| Gross Patient Revenue | 86.4 | |
| Non-Patient Revenue | 13.6 | |
| Total Revenue | ||
| Net Income (or Loss) | -1.5 |
